From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

Danish film director Lars von Trier has been admitted to a care facility for Parkinson’s disease, his producer said Wednesday ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...

Jan. 21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease.

"It has over 40 separate symptoms, everybody has an unusual ... for some time but had been waiting to secure funding. "Parkinson's disease is actually the second-most-common neurodegenerative ...